Inventor · disambiguated record
Bharat Lagu
Also filed as: LAGU BHARAT · LAGU BHARAT R · LAGU BHARAT RAMKRISHNA
46 granted patents·22 pending applications·559 citations·filing 1993–2024
98Inventor score
Files withMITOBRIDGE INC18SYNAPTIC PHARMA CORP14NOVARTIS AG6JANSSEN PHARMACEUTICA NV5BRAIN CHRISTOPHER THOMAS3
Top patents by PatentIndex Score
68 records- 0198US8415355B2Pyrrolopyrimidine compounds and their usesBRAIN CHRISTOPHER THOMAS·Filed 2009·Granted Apr 9, 2013·92 cites·6 claims
- 0295US6620815B1Oxazolidinones and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted Sep 16, 2003·50 cites·40 claims
- 0394US10766888B1HMOX1 inducersMITOBRIDGE INC·Filed 2020·Granted Sep 8, 2020·16 cites·11 claims
- 0494US10399958B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2016·Granted Sep 3, 2019·7 cites·20 claims
- 0594US8685980B2Pyrrolopyrimidine compounds and their usesBESONG GILBERT EBAI·Filed 2009·Granted Apr 1, 2014·81 cites·15 claims
- 0694US6720324B2Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Granted Apr 13, 2004·51 cites·18 claims
- 0791US10479775B1PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2019·Granted Nov 19, 2019·7 cites·20 claims
- 0891US8962630B2Pyrrolopyrimidine compounds and their usesNOVARTIS AG·Filed 2013·Granted Feb 24, 2015·9 cites·17 claims
- 0989US10927094B2Crystalline and salt forms of PPAR agonist compoundsMITOBRIDGE INC·Filed 2017·Granted Feb 23, 2021·3 cites·15 claims
- 1089US7799824B2Quaternary salt CCR2 antagonistsORAPHARMA INC·Filed 2005·Granted Sep 21, 2010·14 cites·35 claims
- 1188US9309252B2Pyrrolopyrimidine compounds as inhibitors of CDK4/6BRAIN CHRISTOPHER THOMAS·Filed 2014·Granted Apr 12, 2016·12 cites·18 claims
- 1287US11578052B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2021·Granted Feb 14, 2023·1 cites·16 claims
- 1387US11530192B2Crystalline and salt forms of PPAR agonist compoundsMITOBRIDGE INC·Filed 2021·Granted Dec 20, 2022·1 cites·10 claims
- 1486US6245773B15-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 1997·Granted Jun 12, 2001·34 cites·19 claims
- 1585US8957074B2Pyrrolopyrimidine compounds as inhibitors of CDK4/6BRAIN CHRISTOPHER THOMAS·Filed 2011·Granted Feb 17, 2015·9 cites·40 claims
- 1685US8481542B2Pyridazinyl derivatives as smo inhibitorsHE FENG·Filed 2012·Granted Jul 9, 2013·7 cites·4 claims
- 1785US6159990AOxazolidinones as α1A receptor antagonistsSYNAPTIC PHARMA CORP·Filed 1998·Granted Dec 12, 2000·66 cites·38 claims
- 1884US10906885B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2019·Granted Feb 2, 2021·1 cites·18 claims
- 1984US9416136B2Pyrrolopyrimidine compounds and their usesBESONG GILBERT·Filed 2014·Granted Aug 16, 2016·8 cites·23 claims
- 2084US2024417383A1Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2024·Application pending·0 cites
- 2183US11034670B2Poly-ADP ribose polymerase (PARP) inhibitorsMITOBRIDGE INC·Filed 2017·Granted Jun 15, 2021·2 cites·30 claims
- 2283US7723326B2Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetesJANSSEN PHARMACEUTICA NV·Filed 2006·Granted May 25, 2010·9 cites·28 claims
- 2382US9409871B2Pyridazinyl derivatives as SMO inhibitorsNOVARTIS AG·Filed 2013·Granted Aug 9, 2016·5 cites·2 claims
- 2482US2024043428A1Pyrrolopyrimidine compounds and their usesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2582US2023373948A1Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2023·Application pending·0 cites
- 2680US11912681B2Crystalline and salt forms of PPAR agonist compoundsMITOBRIDGE INC·Filed 2022·Granted Feb 27, 2024·0 cites·9 claims
- 2776US12071433B2HMOX1 inducersASTELLAS ENG SMALL MOLECULES US INCORPORATED·Filed 2023·Granted Aug 27, 2024·0 cites·11 claims
- 2876US7452997B2Tetrahydro-indazole cannabinoid modulatorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Nov 18, 2008·2 cites·4 claims
- 2974US10968172B2USP30 inhibitorsMITOBRIDGE INC·Filed 2018·Granted Apr 6, 2021·1 cites·20 claims
- 3074US7638533B2Dihydro-1[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetesJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Dec 29, 2009·2 cites·23 claims
- 3174US6727257B15-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 2000·Granted Apr 27, 2004·7 cites·42 claims
- 3273US2021253578A1Pyrrolopyrimidine compounds and their usesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3373US2024409533A1Hmox1 inducersASTELLAS ENG SMALL MOLECULES US INCORPORATED·Filed 2024·Application pending·0 cites
- 3470US6268369B15-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 1995·Granted Jul 31, 2001·28 cites·21 claims
- 3568US7262197B2Phospholipase C inhibitors for use in treating inflammatory disordersJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Aug 28, 2007·3 cites·2 claims
- 3667US6531471B2Morpholinone and morpholine derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Granted Mar 11, 2003·2 cites·55 claims
- 3766US11993585B2Poly-ADP ribose polymerase (PARP) inhibitorsMITOBRIDGE INC·Filed 2021·Granted May 28, 2024·0 cites·20 claims
- 3864US2018155351A1Pyrrolopyrimidine compounds and their usesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 3964US2010041663A1Organic Compounds as Smo InhibitorsNOVARTIS AG·Filed 2009·Application pending·0 cites
- 4063US8598217B2Imidazole derivatives and their use as modulators of cyclin dependent kinasesHOWARD STEVEN·Filed 2010·Granted Dec 3, 2013·1 cites·18 claims
- 4162US6362182B1Morpholinone and morpholine derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted Mar 26, 2002·1 cites·42 claims
- 4260US7427625B2Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 23, 2008·0 cites·19 claims
- 4360US2008300264A1Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitorsCONNOLLY PETER J·Filed 2008·Application pending·0 cites
- 4457US6218390B1Morpholinone and morpholine derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 1998·Granted Apr 17, 2001·11 cites·43 claims
- 4556US2017183352A1Pyrrolopyrimidine compounds and their usesBESONG GILBERT·Filed 2016·Application pending·0 cites
- 4654US8236819B2Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetesLAGU BHARAT·Filed 2009·Granted Aug 7, 2012·0 cites·5 claims
- 4754US6057350AAlpha 1a adrenergic receptor antagonistsMERCK & CO INC·Filed 1998·Granted May 2, 2000·5 cites·24 claims
- 4853US2023025807A1Cd38 inhibitorsMITOBRIDGE INC·Filed 2020·Application pending·0 cites
- 4953US2015183802A1Tricyclic sulfonamide derivativesCHEN SHUHUI·Filed 2014·Application pending·0 cites
- 5053US2003212062A1Morpholinone and morpholine derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2003·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bharat Lagu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →